STAAR Surgical SG&A Expenses 2010-2024 | STAA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

STAAR Surgical sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

STAAR Surgical sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
McKesson (MCK)	$78.2B
Becton Dickinson (BDX)	$64.4B
Cardinal Health (CAH)	$28.6B
West Pharmaceutical Services (WST)	$22B
Labcorp (LH)	$19.8B
Cooper (COO)	$19.7B
Align Technology (ALGN)	$16.6B
Henry Schein (HSIC)	$9.3B
Merit Medical Systems (MMSI)	$6.1B
DENTSPLY SIRONA (XRAY)	$3.8B
CONMED (CNMD)	$2.2B
Patterson (PDCO)	$1.8B
Lifevantage (LFVN)	$170M
Pro-Dex (PDEX)	$147M